Page last updated: 2024-08-17

quinoxalines and sb 225002

quinoxalines has been researched along with sb 225002 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araújo, SB; Calixto, JB; Costa, R; Fernandes, ES; Manjavachi, MN; Passos, GF; Pontes, JP; Trevisan, G	1

Other Studies

1 other study(ies) available for quinoxalines and sb 225002

Article	Year
Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology, 2019, Volume: 151 Topics: Animals; Antineoplastic Agents, Phytogenic; Chemokine CXCL1; Ganglia, Spinal; Mice; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Quinoxalines; Receptors, Interleukin-8B; Signal Transduction; Spinal Cord; Thiazolidinediones	2019

Article

Year

Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice.

Neuropharmacology, 2019, Volume: 151

Topics: Animals; Antineoplastic Agents, Phytogenic; Chemokine CXCL1; Ganglia, Spinal; Mice; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Quinoxalines; Receptors, Interleukin-8B; Signal Transduction; Spinal Cord; Thiazolidinediones

2019